Refocusing vitamin A supplementation programmes to reach the most vulnerable
WHO recommends vitamin A supplementation (VAS) programmes for children 6–59 months where vitamin A deficiency is a public health problem. However, resources for VAS are falling short of current needs and programme coverage is suffering. The authors present the case for considering the options for sh...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-07-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/5/7/e001997.full |
id |
doaj-c16a3cd6309e41df8e7481b80beb76d2 |
---|---|
record_format |
Article |
spelling |
doaj-c16a3cd6309e41df8e7481b80beb76d22021-03-30T13:00:27ZengBMJ Publishing GroupBMJ Global Health2059-79082020-07-015710.1136/bmjgh-2019-001997Refocusing vitamin A supplementation programmes to reach the most vulnerableAlison Greig0Erin McLean1Rolf Klemm2Hamsa Subramaniam3Nutrition International, Ottawa, Ontario, CanadaNutrition, UNICEF, New York City, New York, USAHelen Keller International, New York City, New York, USAUNICEF, New York City, New York, USAWHO recommends vitamin A supplementation (VAS) programmes for children 6–59 months where vitamin A deficiency is a public health problem. However, resources for VAS are falling short of current needs and programme coverage is suffering. The authors present the case for considering the options for shifting efforts and resources from a generalised approach, to prioritising resources to reach populations with continued high child mortality rates and high vitamin A deficiency prevalence to maximise child survival benefits . This includes evaluating where child mortality and/or vitamin A deficiency has dropped, as well as using under 5 mortality rates as a proxy for vitamin A deficiency, in the absence of recent data. The analysis supports that fewer countries may now need to prioritise VAS than in the year 2000, but that there are still a large number of countries that do. The authors also outline next steps for analysing options for improved targeting and cost-effectiveness of programmes. Focusing VAS resources to reach the most vulnerable is an efficient use of resources and will continue to promote young child survival.https://gh.bmj.com/content/5/7/e001997.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alison Greig Erin McLean Rolf Klemm Hamsa Subramaniam |
spellingShingle |
Alison Greig Erin McLean Rolf Klemm Hamsa Subramaniam Refocusing vitamin A supplementation programmes to reach the most vulnerable BMJ Global Health |
author_facet |
Alison Greig Erin McLean Rolf Klemm Hamsa Subramaniam |
author_sort |
Alison Greig |
title |
Refocusing vitamin A supplementation programmes to reach the most vulnerable |
title_short |
Refocusing vitamin A supplementation programmes to reach the most vulnerable |
title_full |
Refocusing vitamin A supplementation programmes to reach the most vulnerable |
title_fullStr |
Refocusing vitamin A supplementation programmes to reach the most vulnerable |
title_full_unstemmed |
Refocusing vitamin A supplementation programmes to reach the most vulnerable |
title_sort |
refocusing vitamin a supplementation programmes to reach the most vulnerable |
publisher |
BMJ Publishing Group |
series |
BMJ Global Health |
issn |
2059-7908 |
publishDate |
2020-07-01 |
description |
WHO recommends vitamin A supplementation (VAS) programmes for children 6–59 months where vitamin A deficiency is a public health problem. However, resources for VAS are falling short of current needs and programme coverage is suffering. The authors present the case for considering the options for shifting efforts and resources from a generalised approach, to prioritising resources to reach populations with continued high child mortality rates and high vitamin A deficiency prevalence to maximise child survival benefits . This includes evaluating where child mortality and/or vitamin A deficiency has dropped, as well as using under 5 mortality rates as a proxy for vitamin A deficiency, in the absence of recent data. The analysis supports that fewer countries may now need to prioritise VAS than in the year 2000, but that there are still a large number of countries that do. The authors also outline next steps for analysing options for improved targeting and cost-effectiveness of programmes. Focusing VAS resources to reach the most vulnerable is an efficient use of resources and will continue to promote young child survival. |
url |
https://gh.bmj.com/content/5/7/e001997.full |
work_keys_str_mv |
AT alisongreig refocusingvitaminasupplementationprogrammestoreachthemostvulnerable AT erinmclean refocusingvitaminasupplementationprogrammestoreachthemostvulnerable AT rolfklemm refocusingvitaminasupplementationprogrammestoreachthemostvulnerable AT hamsasubramaniam refocusingvitaminasupplementationprogrammestoreachthemostvulnerable |
_version_ |
1724180591217213440 |